A fully automated bench-top clinical analyzer (0PTIMATE"; Ames/Gilford)performs homogeneousfluorescentimmunoassays, colorimetricimmunoassays,and determinationsof routinebloodanalytes:drugs,enzymes, metabolites,specific proteins,and hormonesin serum. Uniquefeatures includea combinationfluorescence/absorbanceaspirating thermocuvette, a photon-counting fluorometer/photometer, a multi- (3). The automated therapeutic drug monitoring system we describe has the flexibility to perform both SLP'IA fluorescent assays and colorimetric immunoassays. Moreover, the photometric system can also be used for routine blood analyte tests. These features make the system a highly versatile and fully automated clinical analyzer.
Materials and Methods

Instrumentation
Fluorometer/photometer.
The automated
fluorometer/photometer instrument (Figure 1 ) is a single bench-top unit consisting of an optics module, a sample transport, a computer with a keyboard, printer, a digital diluter, and a pipettor/diluter.
The light paths for the fluorometer/phothmeter, which is located in the upper cabinet, are illustrated in Figure 2 . The stepper-motor-driven excitation ifiter wheel holds the narrow-bandpass interference filters used to select both absorbance and fluorescence excitation wavelengths. Light from the quartz halogen lamp passes through the excitation filter and through the combination fluorescence/ absorbance flow cell to the absorbance photomultiplier.
In the case of a fluorescent sample, a 90#{176} side window in the flow cell allows the fluorescence to be focused on the fluorescence photomultiplier 
Absorbance measurement.
A block diagram of the circuits used for absorbance detection is shown in Figure 4 . The computer sets the appropriate reference current for each ifiter selected to "0" absorbance. The phothmultiplier signal is converted to absorbance units by a differential log amplifier. This signal is converted to a digital signal by an analogto-digital converter for further processing by the computer. The photomultiplier tube and lamp have been selected for their stability in this system. The excitation illumination is enough so that dark-current compensation need not be considered: the signal exceeds dark current by approximately 10 000-fold.
Fluorescence measurement.
In fluorescence detection, the photomultiplier is in the single-photon counting mode, the The lower cabinet ( Figure  1 ) contains a sample transport, keyboad, and computer. The 60-sample transport, together with the diluter modules located in the upper cabinet, is used for handling samples and reagent pipetting, diluting, and dispensing. To corroborate results for triglycerides, cholesterol, and bilirubin tests, we used the Seralyzer#{174} system (Miles Laboratories).
The hemoglobin assay was the leuco-malachite green procedure (6) with reagents purchased from Aldrich Chemical Co., Milwaukee, WI 53233.
Procedures
The immunoassay protocol for SLFIA tests is preprogrammed. The operator pipets a minimum of 50 L of serum into sample cups, loads the reagents, and enters the mode number of the desired assay. The system reads buffer fluorescence, which is subtracted from all measured fluorescence values. For each serum sample, an 8-tL aliquot is automatically diluted into a dilution cup with 400 jL of buffer. Then 20 L of diluted serum, 20 tL of antibodyenzyme reagent, and 300 L of buffer are dispensed into a reaction cup. During a 22-s delay for antibody binding of analyte, the next sample in the set is diluted. To start the assay, 20 .tL of fluorogenic drug reagent and 300 L of buffer are added to the first reaction cup. The sequential sample-dilution and reagent-addition steps are repeated for each sample. After a 273-s reaction period, each sample is aspirated into the flow cell, where it equilibrates at 37 #{176}C for 27 s before its fluorescence is measured by photon counting during a 3-s reading period. Each sample concentration is calculated, printed, and collated as it is read. Calibrator curves are fitted by using a four-parameter logistic model and are stored in battery-backed RAM.
Each 5LFIA kit contains five calibrators covering the normal assay range. Calibration curves for each assay were obtained by duplicate determinations of fluorescence vs kit calibrator concentration for each assay. The data are fit by the instrument to a four-parameter lot-logit function and the four parameters are stored in RAM. Concentrations are calculated from fluorescence by using the stored four-parameters in the log-logit function. "High-performance"
liquid-chromatographic and gaschromatographic assays for theophylline, phenytoin, primidone, carbamazepine, and quinidine (5-7) were all developed and performed by Ames Analytical Services Depart- 3033 (IBM, Inc. , Endicott, NY), with the SAS programming statistics language (SAS Institute, Inc., Cary, NC).
Results
Fluorometer Performance
We used a preprogrammed diagnostic procedure weekly curve with five calibrators in duplicate, followed by the assay of five replicates for each control sample. (Figure 5 ), providing convenience and reliability for "stat" testing and routine analysis.
Sensitivity.
The sensitivity of the SLFIA, defined as the amount of drug in a sample that can be distinguished from zero drug with 95% confidence, was estimated with a series of low-concentration drug samples (seven concentrations each). The fluorescence values of five replicates of each sample in an assay were fitted to a linear or a quadratic curve vs the known concentrations; calculated sensitivities are summarized in Table 3 .
Over-Range Concentration Study
The SLFIA drug assay kit calibrators for standard curves cover the majority of clinically observed drug concentra- tions. The occasional sample having a drug concentration exceeding the limits of the standard curve range will be flagged as "over-range."
As part of the sample rerun mode, the system then automatically dilutes the over-range sample twofold before re-assaying it. The concentration of the diluted sample is then determined from the stored standard curve, multiplied by the dilution factor, and printed out and collated.
To test this over-range sample protocol, we used drug- The calculated results (Table 4) are very close to the gravimetric concentration of the contrived sample. The precision (CV) of these results ranged from 3% to 7%. Table 5 .
Serum Interferences
We tested abnormal serum samples classified as hemolyzed, lipemic, or icteric for interference in the automated SLFIA system.
After supplementing the abnormal sera with known concentrations of drug, we measured the drug concentrations with the SLFIA tests and measured the hemoglobin, triglycerides, cholesterol, and bilirubin with the appro- for normal human serum. The background fluorescence was similar for all normal and abnormal samples, and the drug assay result from each type of sample compared well with those from normal samples. The 1683-fold serum dilution preceding the su'i. reaction appears to eliminate the potential interferences from hemolyzed, lipemic, or icteric samples (8, 9).
Sample Carryover Study
The op'riarx system uses a common reagent dispense probe and a flow-cell cuvette. After the fluorescence measurement of each sample, the reaction mixture is purged by air. In a study to determine the extent of carryover between adjacent samples, we found that percent carryover from zero to high concentrations for the o it'rx assays for phenobarbital, primidone, and tobramycin was 0.5%, 0.2%, and 0.3%, respectively.
The percent carryover from high to zero concentration was 0.4% for phenobarbital, 0.1% for prmiidone, and 0.0% for tobrainycin. Because we measured carryover with calibrators across the entire standard curve range, the values cited should be the maximum encountered;
i.e., there is no significant carryover when the sr.ri assays are run on the automated system.
Discussion
The ornm system is designed to determine routine blood analytes and perform colorimetric and fluorometric homogeneous immunoassays.
The intention is to provide the user with an all-purpose, fully automated serum analyzer for drugs, enzymes, metabolites, specific proteins, and hormones. The user has the flexibility of using absorbance or fluorescence methodologies to quantifr specific analytes. The following unique features of the ovmvIArE system are important and useful to the clinical laboratory.
The combination fluorometric/photometric flow-cell optical system, which utilizes a single-photon Instead of using three dispensers, use of the multi-reagent distribution valve (Figure 1 ) permits the automatic dispensing of up to three reagents when the reagents are incompatible and cannot be premixed.
Using the general test list and operator-defined test modes, users can program their own customized sets of analyses.
Totally automated diagnostic procedures are in- by the user. The immunoassay reagents provide stable calibration curves that can be stored and re-used without recalibration for two weeks. The system can be run on a batch basis, but also has interrupt capabilities to perform assays with use of stored calibration curves. Results can be collated in the system computer for later printout or for transmission to an external computer via the RS-232C
interface.
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